Skip to main content
logo
AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
85.38
-0.49 (-0.57%)
At close: Oct 8, 2025, 4:00 PM EDT
85.36
-0.02 (-0.02%)
After-hours: Oct 8, 2025, 6:39 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
-
Log In
Log In
Log In
Log In
Upgrade
Oncology
20.28B
Log In
Log In
Log In
Log In
Upgrade
Oncology Growth
21.07%
Log In
Log In
Log In
Log In
Upgrade
BioPharmaceuticals: CVRM
12.45B
Log In
Log In
Log In
Log In
Upgrade
BioPharmaceuticals: CVRM Growth
10.83%
Log In
Log In
Log In
Log In
Upgrade
BioPharmaceuticals: R&I
7.42B
Log In
Log In
Log In
Log In
Upgrade
BioPharmaceuticals: R&I Growth
21.18%
Log In
Log In
Log In
Log In
Upgrade
Other Medicines
1.07B
Log In
Log In
Log In
Log In
Upgrade
Other Medicines Growth
-8.28%
Log In
Log In
Log In
Log In
Upgrade
COVID-19
-
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Growth
-
Log In
Log In
Log In
Log In
Upgrade
Collaboration
3.14B
Log In
Log In
Log In
Log In
Upgrade
Collaboration Growth
3.05%
Log In
Log In
Log In
Log In
Upgrade
BioPharmaceuticals V&I
1.06B
Log In
Log In
Log In
Log In
Upgrade
BioPharmaceuticals V&I Growth
28.00%
Log In
Log In
Log In
Log In
Upgrade
Rare Disease
8.67B
Log In
Log In
Log In
Log In
Upgrade
Rare Disease Growth
7.00%
Log In
Log In
Log In
Log In
Upgrade

Capex by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
UK Assets Acquired
582.00M
Log In
Log In
Log In
Log In
Upgrade
UK Assets Acquired Growth
-
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe Assets Acquired
2.23B
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe Assets Acquired Growth
-
Log In
Log In
Log In
Log In
Upgrade
The Americas Assets Acquired
3.93B
Log In
Log In
Log In
Log In
Upgrade
The Americas Assets Acquired Growth
-
Log In
Log In
Log In
Log In
Upgrade
Asia, Africa & Australasia Assets Acquired
1.39B
Log In
Log In
Log In
Log In
Upgrade
Asia, Africa & Australasia Assets Acquired Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
UK Operating Profit
2.68B
Log In
Log In
Log In
Log In
Upgrade
UK Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe Operating Profit
5.92B
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
The Americas Operating Profit
423.00M
Log In
Log In
Log In
Log In
Upgrade
The Americas Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Asia, Africa & Australasia Operating Profit
976.00M
Log In
Log In
Log In
Log In
Upgrade
Asia, Africa & Australasia Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
UK Revenue
4.74B
Log In
Log In
Log In
Log In
Upgrade
UK Revenue Growth
-
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe
11.70B
Log In
Log In
Log In
Log In
Upgrade
Rest of Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade
The Americas
24.99B
Log In
Log In
Log In
Log In
Upgrade
The Americas Growth
-
Log In
Log In
Log In
Log In
Upgrade
Asia, Africa & Australasia
12.64B
Log In
Log In
Log In
Log In
Upgrade
Asia, Africa & Australasia Growth
-
Log In
Log In
Log In
Log In
Upgrade